MDV-3100
MDV-3100 (Enzalutamide) is an androgen-receptor (AR) antagonist (IC₅₀ = 36 nM). Prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis, and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer.
Product Specifications
Shipping Conditions
Gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0019405 3x 1.0 µg
ABCC5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
168312 100 µg
Interleukin 27alpha (IL-27a, p28, IL-27 alpha, IL27-A, p28, IL-30)
Sign In for Pricing
View Details 